Tr1x

Tr1X est le pionnier d'une catégorie révolutionnaire de produits à base de cellules T régulatrices visant à guérir les maladies auto-immunes et inflammatoires, avec le potentiel d'améliorer considérablement la vie des patients.

Pays

USA

Site web

tr1x.bio

Fondé en

2018

Réseaux sociaux

Source d'information :

www.tr1x.bio/

Ajouter à ma liste

Equipes dirigeantes

Bill Lis

Chief Executive Officer

Maria Grazia Roncarolo, MD

Co-founder, President and Head of R&D

David de Vries, MPhil

Co-founder, Chief Operating Officer

Industries

Med Tech

Ajoutez votre entreprise

Disclaimer

The content of this website is not directed at or intended for persons in the United Kingdom or any other jurisdiction where the provision of the website or services would breach any applicable law or registration or would require any registration or license in any such jurisdiction. The content of this website should not be regarded as an invitation or inducement to engage in investment activity, to any person in the United Kingdom and investment opportunities described on this website are not intended to be acted upon by any persons in the United Kingdom.